TARS Tarsus Pharmaceuticals
- 32.810
- +0.770+2.40%
Tarsus Pharmaceuticals News
Tarsus Pharmaceuticals | ARS: Annual Report to Security Holders
Tarsus Pharmaceuticals | DEFA14A: Others
Tarsus Pharmaceuticals | DEF 14A: Definitive information statements
Tarsus Pharmaceuticals | 8-K: Current report
Tarsus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Tarsus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mottiwala Aziz
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Wahl Bryan
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Azamian Bobak R.
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Whitfield Dianne C.
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Neervannan Seshadri
Tarsus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Tarsus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Tarsus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Tarsus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Tarsus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Azamian Bobak R.
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Wahl Bryan
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mottiwala Aziz
Tarsus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Neervannan Seshadri
Analysis
Price Target
No Data
